E
Ehab R. Bendas
Researcher at Future University in Egypt
Publications - 32
Citations - 1169
Ehab R. Bendas is an academic researcher from Future University in Egypt. The author has contributed to research in topics: Bioavailability & Transdermal. The author has an hindex of 16, co-authored 30 publications receiving 960 citations. Previous affiliations of Ehab R. Bendas include Cairo University & Oregon State University.
Papers
More filters
Journal ArticleDOI
Enhanced transdermal delivery of salbutamol sulfate via ethosomes
TL;DR: In vitro permeation studies of the prepared gels containing the selected vesicles showed that ethosomal systems were much more efficient at delivering SS into mice skin than were liposomes or aqueous or hydroalcoholic solutions.
Journal ArticleDOI
Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.
Shaimaa El-Housiny,Maii Atef Shams Eldeen,Yasmina Ahmed El-Attar,Hoda A Salem,Dalia A. Attia,Ehab R. Bendas,Mohamed A. El-Nabarawi +6 more
TL;DR: Findings of the study suggest that the developed FLZ loaded SLNs topical gels have superior significant fast therapeutic index in treatment of PV over commercially available Candistan® cream.
Journal ArticleDOI
Intranasal Microemulsion of Sildenafil Citrate: In Vitro Evaluation and In Vivo Pharmacokinetic Study in Rabbits
TL;DR: The nasal absorption of sildenafil citrate microemulsion was found to be fast, indicating the potential of nasal delivery instead of the conventional oral administration of such drug.
Journal ArticleDOI
Preparation and Evaluation of Self-nanoemulsifying Tablets of Carvedilol
TL;DR: The purpose of this study was to combine the advantages of self-nanoemulsifying drug delivery systems and tablets as a conventional dosage form emphasizing the excipients’ effect on the development of a new dosage form.
Journal ArticleDOI
Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
TL;DR: The aim of this work is to explore the potential of novel nanovesicular fatty acid enriched structures (novasomes) for effective and enhanced nasal delivery of zolmitriptan and investigate their nose to brain targeting potential.